{"id":391091,"date":"2016-08-04T00:00:00","date_gmt":"2016-08-04T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/acreon0006-2016-biopharma-colorectal-cancer-access-and-reimbursement-optimal-sequencing-of-angiogenesis-and-egfr\/"},"modified":"2026-04-30T23:46:57","modified_gmt":"2026-04-30T23:46:57","slug":"acreon0006-2016-biopharma-colorectal-cancer-access-and-reimbursement-optimal-sequencing-of-angiogenesis-and-egfr","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/acreon0006-2016-biopharma-colorectal-cancer-access-and-reimbursement-optimal-sequencing-of-angiogenesis-and-egfr\/","title":{"rendered":"Colorectal Cancer | Access and Reimbursement | Optimal Sequencing of Angiogenesis and EGFR Inhibitors in Colorectal Cancer | US | 2016"},"content":{"rendered":"<p>Seven premium-priced therapies\u2014Avastin, Erbitux, Vectibix, Zaltrap, Stivarga, Lonsurf, and Cyramza\u2014are approved in the United States for metastatic colorectal cancer. Therefore, medical oncologists\u00a0have numerous treatment options for their metastatic colorectal cancer patients, and are looking to optimize the sequencing of these therapies in a way that will lead to the maximal outcome for patients and make the most efficient use of available funds.<\/p>\n","protected":false},"template":"","class_list":["post-391091","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-colorectal-cancer","biopharma-geography-us","biopharma-date-858"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391091\/revisions"}],"predecessor-version":[{"id":394214,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391091\/revisions\/394214"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}